Literature DB >> 14673666

Indications for endoscopic thoracic sympathectomy.

Göran Claes1.   

Abstract

The thoracoscopic approach to the sympathetic chain has diminished the trauma of previous open sympathectomy. The minimal trauma has opened the way to manipulate the chain for several conditions. Hand sweat is the most common indication resulting in patient satisfaction 2-13 years after surgery in more than 90%. High satisfaction was also obtained in patients with angina pectoris and a very disabling condition, facial blushing (85 %). Somewhat poorer results were obtained in patients with facial and axillary sweating. In patients with Mb Raynaud-all had recurrences within a year. Since severe side effects, especially compensatory sweating, may occur, the ETS procedure should be reserved only for patients with severe problems where other treatments have failed.

Entities:  

Mesh:

Year:  2003        PMID: 14673666     DOI: 10.1007/s10286-003-1106-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  4 in total

Review 1.  Hyperhidrosis--causes and treatment of enhanced sweating.

Authors:  Tanja Schlereth; Marianne Dieterich; Frank Birklein
Journal:  Dtsch Arztebl Int       Date:  2009-01-16       Impact factor: 5.594

2.  Endoscopic thoracic sympathectomy for posttraumatic complex regional pain syndrome.

Authors:  K Demey; S Nijs; W Coosemans; H Decaluwé; G Decker; P De Leyn; D Van Raemdonck; A Sermon; P Broos; T Lerut; P Nafteux
Journal:  Eur J Trauma Emerg Surg       Date:  2011-02-22       Impact factor: 3.693

3.  Sustained benefit lasting one year from T4 instead of T3-T4 sympathectomy for isolated axillary hyperhidrosis.

Authors:  Marco Antonio S Munia; Nelson Wolosker; Paulo Kaufmann; José Ribas Milanes de Campos; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

4.  Is the result of modified Allen's test still accurate after endoscopic thoracic sympathectomy?

Authors:  Jiaheng Zhang; Yuanjun Cheng; Donglai Chen; Fuquan Zhang; Shanzhou Duan; Lei Chen; Chang Chen; Yonghua Sang; Li Shi; Wentao Yang; Yongbing Chen
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.